Jun 1 |
Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Updates
|
May 29 |
Karyopharm to Participate at the Jefferies Global Healthcare Conference
|
May 23 |
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
|
May 10 |
Karyopharm Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
May 9 |
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q1 2024 Earnings Call Transcript
|
May 9 |
Karyopharm Therapeutics Inc (KPTI) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
|
May 9 |
Q1 2024 Karyopharm Therapeutics Inc Earnings Call
|
May 8 |
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
|
May 8 |
Karyopharm to Participate at the 2024 RBC Capital Markets Global Healthcare Conference
|
May 8 |
Karyopharm Therapeutics Inc. (KPTI) Q1 2024 Earnings Call Transcript
|